DEVICE CATEGORY · QNH
Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay
The DNA Mismatch Repair Protein Antibody is a qualitative immunohistochemical antibody intended for the assessment of mismatch repair (MMR) proteins in human clinical tissue specimens. The DNA Mismatch Repair Protein Antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
VENTANA MMR RxDx PanelP200019/S014 | Ventana Medical Systems | PMA supplement | Oct 8, 2026 | FDA |
VENTANA MMR RxDx PanelP210001/S016 | Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) | PMA supplement | Oct 8, 2026 | FDA |
MMR IHC Panel pharmDx (Dako Omnis)P250004/S001 | Agilent Technologies, Inc. | PMA supplement | Sep 11, 2026 | FDA |
VENTANA anti-MSH6 (SP93) AntibodyP200019/S013 | Ventana Medical Systems | PMA supplement | Jan 6, 2026 | FDA |
VENTANA anti-MSH6 (SP93) AntibodyP210001/S015 | Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) | PMA supplement | Jan 6, 2026 | FDA |
| Agilent Technologies, Inc. | PMA approval | Aug 15, 2025 | FDA | |
VENTANA MMR RxDx PanelP210001 | Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) | PMA approval | Aug 17, 2021 | FDA |
VENTANA MMR RxDx PanelP200019 | Ventana Medical Systems | PMA approval | Apr 22, 2021 | FDA |
Source information
Follow the FDA links to view the original records.



